What is Crinetics Pharmaceuticals's net investment in lease?

Crinetics Pharmaceuticals (CRNX) reported net investment in lease of $39.79M in Q1 2026.

How has Crinetics Pharmaceuticals's net investment in lease changed year-over-year?

Crinetics Pharmaceuticals's net investment in lease decreased by 6.8% year-over-year, from $42.69M to $39.79M.

What is the long-term trend for Crinetics Pharmaceuticals's net investment in lease?

Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's net investment in lease has grown at a 78.5% compound annual growth rate (CAGR), from $2.23M to $40.49M.

Crinetics Pharmaceuticals CRNX Net Investment in Lease

Net Investment in Lease at other companies

Neurocrine BiosciencesNBIX

——

Corcept TherapeuticsCORT

——

Viking TherapeuticsVKTX

——

Catalyst PharmaceuticalCPRX

——

Rhythm Pharmaceuticals, Inc.RYTM

——

LQD

Liquidia CorporationLQDA

——

Other financials

Income statement

See full

Revenue$10.7M+2,873%

Gross profit$10.5M+2,818%

Operating income-$140.4M-26.0%

Net income-$127.8M-32.1%

EPS (diluted)-$1.23-18.3%

Balance sheet

See full

Cash & equivalents$115.1M+20.1%

Total debt$47.9M-5.8%

Total equity$1.3B+2.1%

Total assets$1.4B+2.9%

Cash flow

See full

Operating cash flow-$124.7M-41.0%

CapEx$820.0K-33.8%

Free cash flow-$125.5M-40.0%

Valuation

See full

Market cap$3.79B+21.9%

Profitability

See full

Gross margin150%-15.6pp

Operating margin-3,020.3%-1,463pp

Net margin-2,747.2%-1,328pp

FCF margin-2,321.7%-1,122pp

Returns & leverage

See full

Return on equity-39.2%+14.5pp

Debt / equity0×0.0×

Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Crinetics Pharmaceuticals's net investment in lease?: Crinetics Pharmaceuticals (CRNX) reported net investment in lease of $39.79M in Q1 2026.
How has Crinetics Pharmaceuticals's net investment in lease changed year-over-year?: Crinetics Pharmaceuticals's net investment in lease decreased by 6.8% year-over-year, from $42.69M to $39.79M.
What is the long-term trend for Crinetics Pharmaceuticals's net investment in lease?: Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's net investment in lease has grown at a 78.5% compound annual growth rate (CAGR), from $2.23M to $40.49M.